The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.
Thanks so much for your helpful reply. It looks like TAVO + pembro may be more promising than T-VEC + pembro because of the demonstrated benefit (in KEYNOTE-695) in patients with anti-PD-1 checkpoint resistance. I wonder if it would be worth looking into the possibility of expanded access for TAVO + pembro? Does anyone on the forum have experience with expanded access?